Anika Therapeutics
Stock Forecast, Prediction & Price Target
Anika Therapeutics Financial Estimates
Anika Therapeutics Revenue Estimates
Anika Therapeutics EBITDA Estimates
Anika Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $147.79M N/A | $156.23M 5.71% | $166.66M 6.67% | Avg: $181.88M Low: $181.00M High: $183.38M avg. 9.13% | Avg: $193.60M Low: $192.66M High: $195.19M avg. 6.44% | Avg: $215.6M Low: $214.55M High: $217.37M avg. 11.35% | Avg: $235.3M Low: $234.15M High: $237.23M avg. 9.13% |
Net Income
% change YoY
| $4.13M N/A | $-14.85M -459.43% | $-82.66M -456.34% | Avg: $8.51M Low: $4.54M High: $13.48M avg. 110.29% | Avg: $9.34M Low: $7.91M High: $10.40M avg. 9.81% | Avg: $15.68M Low: $15.58M High: $15.84M avg. 67.74% | Avg: $20.95M Low: $20.82M High: $21.18M avg. 33.64% |
EBITDA
% change YoY
| $-39.57M N/A | $-19.4M 50.97% | $-11.23M 42.10% | Avg: $-6.00M Low: $-6.05M High: $-5.97M avg. 46.52% | Avg: $-6.39M Low: $-6.44M High: $-6.36M avg. -6.44% | Avg: $-7.11M Low: $-7.17M High: $-7.08M avg. -11.35% | Avg: $-7.77M Low: $-7.83M High: $-7.73M avg. -9.13% |
EPS
% change YoY
| $0.29 N/A | -$1.02 -451.72% | -$5.64 -452.94% | Avg: $0.58 Low: $0.31 High: $0.92 avg. 110.28% | Avg: $0.63 Low: $0.54 High: $0.71 avg. 7.75% | Avg: $1.07 Low: $1.06 High: $1.08 avg. 71.2% | Avg: $1.43 Low: $1.42 High: $1.45 avg. 33.64% |
Operating Expenses
% change YoY
| $101.42M N/A | $112.97M 11.39% | $191.47M 69.48% | Avg: $86.74M Low: $86.32M High: $87.45M avg. -54.69% | Avg: $92.33M Low: $91.88M High: $93.09M avg. 6.44% | Avg: $102.82M Low: $102.32M High: $103.66M avg. 11.35% | Avg: $112.21M Low: $111.67M High: $113.13M avg. 9.13% |
FAQ
What is Anika Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 55.37% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is 4.54M, average is 8.51M and high is 13.48M.
What is Anika Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.01% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $181.00M, average is $181.88M and high is $183.38M.
What is Anika Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 55.72% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is $0.31, average is $0.58 and high is $0.92.